All4NutraNo products in the cart.
All4NutraStartseite » News » Dry Powder Inhalers (DPI) » Page 13
High dose inhaled powders have received increased attention for treating lung infections. These powders can be prepared using techniques such...
Objective The therapeutic options for severe asthma are limited, and the biological therapies are all parenterally administered. The purpose of...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent responsible for the COVID-19 pandemic, has outspread at full tilt...
Respiratory diseases are a global burden, with millions of deaths attributed to pulmonary illnesses and dysfunctions. Therapeutics have been developed,...
This study aims to investigate the effect of physicochemical properties and aerosol performance of two (2FN) and three-fluid nozzles (3FN)...
The study presents inhalable balloon-like hollow spherical salbutamol sulfate micro-particles (SSμb) as potential carrier-free alternative to drug-excipient formulation for dry...
Purpose This study evaluated the in vitro aerosol performance of a dry powder antibiotic product that combined a highly dispersible tobramycin powder...
In the current work, we aimed to deliver high dose of voriconazole (VRC) to lung through dry powder for inhalation (DPIs). Furthermore,...
Twin-screw extruders are useful in tuning certain product characteristics due to the ability to greatly modify screw profiles as well...
Capsule-based, single-dose dry powder inhalers (DPIs) are commonly-used devices to deliver medications to the lungs. This work evaluates the effect of the...
Copyright: PharmaExcipients AG